Klinique Med Number Of Employees vs. Price To Sales

KLINIQ Stock   31.75  1.00  3.05%   
Based on the measurements of profitability obtained from Klinique Med's financial statements, The Klinique Med may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Klinique Med's ability to earn profits and add value for shareholders.
For Klinique Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Klinique Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well The Klinique Med utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Klinique Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of The Klinique Med over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Klinique Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Klinique Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klinique Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Klinique Med Price To Sales vs. Number Of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Klinique Med's current stock value. Our valuation model uses many indicators to compare Klinique Med value to that of its competitors to determine the firm's financial worth.
The Klinique Med is currently regarded as number one stock in number of employees category among its peers. It also is currently regarded as number one stock in price to sales category among its peers fabricating about  2.87  of Price To Sales per Number Of Employees. Comparative valuation analysis is a catch-all model that can be used if you cannot value Klinique Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Klinique Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Klinique Number Of Employees vs. Competition

The Klinique Med is currently regarded as number one stock in number of employees category among its peers. The total workforce of Personal Services industry is now estimated at about 134. Klinique Med claims roughly 2.0 in number of employees contributing just under 2% to equities listed under Personal Services industry.

Klinique Price To Sales vs. Number Of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Klinique Med

Number of Employees

 = 

Full Time

+

Part Time

 = 
2
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Klinique Med

P/S

 = 

MV Per Share

Revenue Per Share

 = 
5.73 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Klinique Price To Sales Comparison

Klinique Med is currently under evaluation in price to sales category among its peers.

Klinique Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Klinique Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Klinique Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Klinique Med's important profitability drivers and their relationship over time.

Use Klinique Med in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klinique Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klinique Med will appreciate offsetting losses from the drop in the long position's value.

Klinique Med Pair Trading

The Klinique Med Pair Trading Analysis

The ability to find closely correlated positions to Klinique Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klinique Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klinique Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Klinique Med to buy it.
The correlation of Klinique Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klinique Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klinique Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klinique Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Klinique Med position

In addition to having Klinique Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Disruptive Technologies Thematic Idea Now

Disruptive Technologies
Disruptive Technologies Theme
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 64 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Klinique Stock

To fully project Klinique Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Klinique Med at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Klinique Med's income statement, its balance sheet, and the statement of cash flows.
Potential Klinique Med investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Klinique Med investors may work on each financial statement separately, they are all related. The changes in Klinique Med's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Klinique Med's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.